[1]HE L,HU P,SHEN HJ.Research progress in HBV/HCV co-infection[J].J Clin Hepatol,2014,30(6):569-572.(in Chinese)何丽,胡萍,申焕君,等.HBV/HCV重叠感染的研究进展[J].临床肝胆病杂志,2014,30(6):569-572.
|
[2]MA Z,LI Y.Observation on risk of overlapping infection by HBV and HCV[J].J Clin Exp Med,2011,10(11):821-822.(in Chinese)马征,李杨.丙肝病毒与乙肝病毒重叠感染几率观察[J].临床和实验医学杂志,2011,10(11):821-822.
|
[3]KONSTANTINOU D,DEUTSCH M.The spectrum of HBV/HCV coinfection:epidemiology,clinical,characteristics,viralinter-actions and management[J].Ann Gastroenterol,2015,28(2):221-228.
|
[4]RAIMONDO G,CACCAMO G,FILOMIA R,et al.Occult HBV infection[J].Semin Immunopathol,2013,35(1):39-52.
|
[5]TAN YW.Antiviral treatment of hepatitis B virus and hepatitis C virus co-infection[J].World Chin J Dig,2011,19(15):1614-1619.(in Chinese)谭友文.HBV/HCV重叠感染的抗病毒治疗[J].世界华人消化杂志,2011,19(15):1614-1619.
|
[6]ZHENG J,ZENG AZ.Research progress in the relationship between occult hepatitis and hepatocellular carcinoma[J].J Chongqing Med Univ,2015,40(3):171-173.(in Chinese)郑洁,曾爱忠.隐匿性乙肝与肝细胞肝癌关系的研究进展[J].重庆医科大学学报,2015,40(3):171-173.
|
[7]LUO YZ,LI TJ.Role of Kupffer cells in hepatitis B/C viral hepatitis[J].World Chin J Dig,2015,23(15):2397-2403.(in Chinese)罗玉政,李铁军.Kupffer细胞在乙型/丙型病毒性肝炎中的作用[J].世界华人消化杂志,2015,23(15):2397-2403.
|
[8]SHEN HY,CHEN YR,SHEN JL.Study on changes in biochemical immune parameters in patients co-infected with HCV and HCV[J].Chin J Nosocomiol,2015,25(13):2889-2893.(in Chinese)沈红元,陈玉蓉,沈建林.乙型肝炎病毒及丙型肝炎病毒重叠感染患者生化免疫指标变化与临床意义[J].中华医院感染学杂志,2015,25(13):2889-2893.
|